Terms: = Breast cancer AND SYK, P43405, 6850, ENSG00000165025
104 results:
1. A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors.
Juric D; Barve M; Vaishampayan U; Roda D; Calvo A; Jañez NM; Trigo J; Greystoke A; Harvey RD; Olszanski AJ; Opyrchal M; Spira A; Thistlethwaite F; Jiménez B; Sappal JH; Kannan K; Riley J; Li C; Li C; Gregory RC; Miao H; Wang S
Cancer Med; 2024 Mar; 13(5):. PubMed ID: 38501219
[TBL] [Abstract] [Full Text] [Related]
2. The amino-dipeptidyl peptidases DPP8 and DPP9: Purification and enzymatic assays.
Donzelli L; Bolgi O; Geiss-Friedlander R
Methods Enzymol; 2023; 684():289-323. PubMed ID: 37230592
[TBL] [Abstract] [Full Text] [Related]
3. Combination of bendamustine-azacitidine against syk target of breast cancer: an
Muthumanickam S; Ramachandran B; Boomi P; Jeyakanthan J; Prabu HG; Jegatheswaran S; Premkumar K
J Biomol Struct Dyn; 2023; 41(23):13950-13962. PubMed ID: 37098715
[TBL] [Abstract] [Full Text] [Related]
4. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
[TBL] [Abstract] [Full Text] [Related]
5. A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
Liu S; Du S; Gao S; Teng Y; Jin F; Zhang L
BMC Cancer; 2023 Jan; 23(1):15. PubMed ID: 36604679
[TBL] [Abstract] [Full Text] [Related]
6. CD16
Liu X; Lu Y; Huang J; Xing Y; Dai H; Zhu L; Li S; Feng J; Zhou B; Li J; Xia Q; Li J; Huang M; Gu Y; Su S
Cancer Cell; 2022 Nov; 40(11):1341-1357.e13. PubMed ID: 36379207
[TBL] [Abstract] [Full Text] [Related]
7. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
8. Tumor cell syk expression modulates the tumor immune microenvironment composition in human cancer via TNF-α dependent signaling.
Aguirre-Ducler A; Gianino N; Villarroel-Espindola F; Desai S; Tang D; Zhao H; Syrigos K; Trepicchio WL; Kannan K; Gregory RC; Schalper KA
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35868661
[TBL] [Abstract] [Full Text] [Related]
9. American Joint Committee on cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
[TBL] [Abstract] [Full Text] [Related]
10. Identification of targetable kinases in idiopathic pulmonary fibrosis.
Higo H; Ohashi K; Tomida S; Okawa S; Yamamoto H; Sugimoto S; Senoo S; Makimoto G; Ninomiya K; Nakasuka T; Nishii K; Taniguchi A; Kubo T; Ichihara E; Hotta K; Miyahara N; Maeda Y; Toyooka S; Kiura K
Respir Res; 2022 Feb; 23(1):20. PubMed ID: 35130915
[TBL] [Abstract] [Full Text] [Related]
11. DOCK2 regulates antifungal immunity by regulating RAC GTPase activity.
Ma X; Tan X; Yu B; Sun W; Wang H; Hu H; Du Y; He R; Gao R; Peng Q; Cui Z; Pan T; Feng X; Wang J; Xu C; Zhu B; Liu W; Wang C
Cell Mol Immunol; 2022 May; 19(5):602-618. PubMed ID: 35079145
[TBL] [Abstract] [Full Text] [Related]
12. Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors.
Jan CI; Huang SW; Canoll P; Bruce JN; Lin YC; Pan CM; Lu HM; Chiu SC; Cho DY
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34663641
[TBL] [Abstract] [Full Text] [Related]
13. Spleen tyrosine kinase (syk) inhibitor PRT062607 protects against ovariectomy-induced bone loss and breast cancer-induced bone destruction.
Xie G; Liu W; Lian Z; Xie D; Yuan G; Ye J; Lin Z; Wang W; Zeng J; Shen H; Wang X; Feng H; Cong W; Yao G
Biochem Pharmacol; 2021 Jun; 188():114579. PubMed ID: 33895161
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors.
Liu YF; Liu JE; Zhu Y; Mak YW; Qiu H; Liu LH; Yang SS; Chen SH
Support Care Cancer; 2021 Sep; 29(9):5435-5445. PubMed ID: 33704565
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of syk Signaling Networks Reveals the Potential Molecular Determinants of Its Tumor-Promoting and Suppressing Functions.
Buffard M; Naldi A; Freiss G; Deckert M; Radulescu O; Coopman PJ; Larive RM
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670716
[TBL] [Abstract] [Full Text] [Related]
16. A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age.
Yu J; Wu J; Huang O; He J; Zhu L; Chen W; Li Y; Chen X; Shen K
J Transl Med; 2021 Feb; 19(1):75. PubMed ID: 33593381
[TBL] [Abstract] [Full Text] [Related]
17. Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expression.
Murugesan G; Correia VG; Palma AS; Chai W; Li C; Feizi T; Martin E; Laux B; Franz A; Fuchs K; Weigle B; Crocker PR
Glycobiology; 2021 Jan; 31(1):44-54. PubMed ID: 32501471
[TBL] [Abstract] [Full Text] [Related]
18. Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3.
Mammadova-Bach E; Gil-Pulido J; Sarukhanyan E; Burkard P; Shityakov S; Schonhart C; Stegner D; Remer K; Nurden P; Nurden AT; Dandekar T; Nehez L; Dank M; Braun A; Mezzano D; Abrams SI; Nieswandt B
Blood; 2020 Apr; 135(14):1146-1160. PubMed ID: 32040544
[TBL] [Abstract] [Full Text] [Related]
19. Expression of syk and MAP4 proteins in ovarian cancer.
Zhang S; Deen S; Storr SJ; Yao A; Martin SG
J Cancer Res Clin Oncol; 2019 Apr; 145(4):909-919. PubMed ID: 30737623
[TBL] [Abstract] [Full Text] [Related]
20. Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in breast cancer.
Shinde A; Hardy SD; Kim D; Akhand SS; Jolly MK; Wang WH; Anderson JC; Khodadadi RB; Brown WS; George JT; Liu S; Wan J; Levine H; Willey CD; Krusemark CJ; Geahlen RL; Wendt MK
Cancer Res; 2019 Apr; 79(8):1831-1843. PubMed ID: 30733195
[TBL] [Abstract] [Full Text] [Related]
[Next]
